China BioMed Innovation and Investment Conference (CBIIC)

China BioMed Innovation and Investment Conference (CBIIC) was established and initiated by China Pharmaceutical Innovation and Research Development Association (PhIRDA) in 2016. As an annual grand conference to promote the communication between pharmaceutical industry and investment industry, CBIIC aims to integrate the power of pharmaceutical innovation and investment at home and abroad to build an authorized, comprehensive, professional and international high level platform where the industry leaders, experts, scholars, domestic and foreign pharmaceutical innovation enterprises and investors can learn the trend of innovation, seek high value projects and discuss new investment channels and innovative cooperation strategies to facilitate the timely transformation of unmet clinical needs and promote the pharmaceutical innovation serve the public health. 2019 China BioMed Innovation and Investment Conference (CBIIC) will be held in Suzhou Industrial Park in September 21-23, 2019. As an annual grand conference to promote the communication between pharmaceutical industry and investment industry, CBIIC was established and initiated by China Pharmaceutical Innovation and Research Development Association (PhIRDA) in 2016. Over 6,500 participants attended CBIIC, 25 new drugs had made their global first clinical trial data release, more than 300 innovative projects at home and abroad had presented in the roadshows, representatives from 1,500 pharmaceutical enterprises and 1,000 investment institutions participated in this event. To check out more: http://cbiic.phirda.com/